Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 9,872 |
|
|||||
| News | - | ||||||
| Day High | 0.76 | Low High |
|||||
| Day Low | 0.73 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MIRA Pharmaceuticals Inc | MIRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0099 | -1.30% | 0.75 | 18:06:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.76 | 0.73 | 0.76 | 0.75 | 0.7599 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 56 | 9,872 | $ 0.7497956 | $ 7,402 | - | 0.72 - 7.9799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:23:16 | formt | 100 | $ 0.7424 | USD |
MIRA Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.09M | 14.78M | - | 0 | -11.98M | -0.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MIRA Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.802 | 0.855499 | 0.72 | 0.7412927 | 88,867 | -0.052 | -6.48% |
| 1 Month | 1.01 | 1.014 | 0.72 | 0.798275 | 46,844 | -0.26 | -25.74% |
| 3 Months | 1.13 | 1.84 | 0.72 | 1.48 | 626,881 | -0.38 | -33.63% |
| 6 Months | 1.53 | 6.40 | 0.72 | 1.79 | 466,233 | -0.78 | -50.98% |
| 1 Year | 7.00 | 7.9799 | 0.72 | 2.10 | 331,456 | -6.25 | -89.29% |
| 3 Years | 7.00 | 7.9799 | 0.72 | 2.10 | 331,456 | -6.25 | -89.29% |
| 5 Years | 7.00 | 7.9799 | 0.72 | 2.10 | 331,456 | -6.25 | -89.29% |
MIRA Pharmaceuticals Description
| MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. |
